Healthy Inc > Blog > Artemether Lumefantrine BP/USP
Posted on:

What is the use of Artemether and Lumefantrine tablets?

In the pharmaceutical industry, Artemether and Lumefantrine tablets (available in 20 mg/120 mg or 80 mg/480 mg strengths) represent the gold standard in Artemisinin-based Combination Therapy (ACT). As a pharmacist, I view this specific fixed-dose combination (FDC) as the most critical frontline defense against multi-drug resistant malaria.

Primary Clinical Uses

  • Uncomplicated Malaria: Indicated for the treatment of acute, uncomplicated malaria infections caused by Plasmodium falciparum, including infections acquired in chloroquine-resistant areas.

  • Pediatric and Adult Populations: Used widely across all age groups (standardized by weight) to ensure rapid clearance of parasites from the blood.

  • Stand-by Emergency Treatment: Often carried by travelers to malaria-endemic regions as a self-administered emergency treatment when medical facilities are unavailable.

Mechanism of Action

This combination provides a dual-phase attack on the malaria parasite:

Artemether: A semi-synthetic derivative of artemisinin. It acts rapidly to provide a fast “knockdown” of the parasite load by generating reactive free radicals that disrupt the parasite’s membrane and proteins.

Lumefantrine: A long-acting fluorene derivative. It acts more slowly but stays in the system longer to clear any residual parasites that survived the initial Artemether burst, preventing recrudescence (relapse).

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Artemether-Lumefantrine is a high-precision product requiring stringent quality controls:

  • Fixed-Dose Combination (FDC) Stability: Artemether is a relatively unstable molecule sensitive to heat and moisture. As a WHO-GMP manufacturer, we utilize specialized granulation processes and Alu-Alu blister packaging to ensure stability, particularly for export to the high-heat environments of Africa and Southeast Asia.

  • Bioavailability: Lumefantrine has highly variable absorption. Our formulation includes specific excipients to ensure consistent absorption, especially when taken with fatty foods, which is a critical clinical requirement.

  • Global Health Tenders: This is a high-volume item for international NGOs, UNICEF, and the Global Fund. Our Mumbai-based facility is optimized to meet the massive demand for these tenders with full CTD/eCTD Dossier support.

  • Pediatric Dispersible Tablets: We also focus on dispersible formulations with pleasant flavoring to ensure easy administration and compliance in children, which is vital for reducing child mortality.

Artemether & Lumefantrine Tablets

Posted on:

What is the use of Artemether and Lumefantrine tablets?

In the pharmaceutical industry, Artemether and Lumefantrine tablets (available in 20 mg/120 mg or 80 mg/480 mg strengths) represent the gold standard in Artemisinin-based Combination Therapy (ACT). As a pharmacist, I view this specific fixed-dose combination (FDC) as the most critical frontline defense against multi-drug resistant malaria.

Primary Clinical Uses

  • Uncomplicated Malaria: Indicated for the treatment of acute, uncomplicated malaria infections caused by Plasmodium falciparum, including infections acquired in chloroquine-resistant areas.

  • Pediatric and Adult Populations: Used widely across all age groups (standardized by weight) to ensure rapid clearance of parasites from the blood.

  • Stand-by Emergency Treatment: Often carried by travelers to malaria-endemic regions as a self-administered emergency treatment when medical facilities are unavailable.

Mechanism of Action

This combination provides a dual-phase attack on the malaria parasite:

Artemether: A semi-synthetic derivative of artemisinin. It acts rapidly to provide a fast “knockdown” of the parasite load by generating reactive free radicals that disrupt the parasite’s membrane and proteins.

Lumefantrine: A long-acting fluorene derivative. It acts more slowly but stays in the system longer to clear any residual parasites that survived the initial Artemether burst, preventing recrudescence (relapse).

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Artemether-Lumefantrine is a high-precision product requiring stringent quality controls:

  • Fixed-Dose Combination (FDC) Stability: Artemether is a relatively unstable molecule sensitive to heat and moisture. As a WHO-GMP manufacturer, we utilize specialized granulation processes and Alu-Alu blister packaging to ensure stability, particularly for export to the high-heat environments of Africa and Southeast Asia.

  • Bioavailability: Lumefantrine has highly variable absorption. Our formulation includes specific excipients to ensure consistent absorption, especially when taken with fatty foods, which is a critical clinical requirement.

  • Global Health Tenders: This is a high-volume item for international NGOs, UNICEF, and the Global Fund. Our Mumbai-based facility is optimized to meet the massive demand for these tenders with full CTD/eCTD Dossier support.

  • Pediatric Dispersible Tablets: We also focus on dispersible formulations with pleasant flavoring to ensure easy administration and compliance in children, which is vital for reducing child mortality.

Artemether & Lumefantrine Tablets

Posted on:

What is the use of Artemether and Lumefantrine dispersible tablet?

In the pharmaceutical industry, Artemether and Lumefantrine dispersible tablets (standardized at 20 mg / 120 mg) are the specialized pediatric formulation of the gold-standard Artemisinin-based Combination Therapy (ACT). As a pharmacist, I view the “dispersible” delivery system as a life-saving innovation designed to ensure accurate dosing and rapid absorption in infants and children, who are the most vulnerable to malaria.

Primary Clinical Uses

  • Pediatric Uncomplicated Malaria: Specifically indicated for the treatment of acute, uncomplicated malaria caused by Plasmodium falciparum in infants and children weighing between 5 kg and 35 kg.

  • Chloroquine-Resistant Strains: First-line defense in regions where malaria parasites have developed resistance to older monotherapies.

  • Rapid Parasite Clearance: Used to quickly reduce the parasite biomass in the blood to prevent the progression of uncomplicated malaria into life-threatening severe or cerebral malaria.

Mechanism of Action

This combination employs a “dual-speed” parasiticidal effect:

Artemether: A fast-acting component that generates reactive free radicals. These radicals damage the parasite’s proteins and membranes, providing an immediate “knockdown” of the infection.

Lumefantrine: A long-acting component that clears any remaining parasites over several days. Its presence in the blood prevents the infection from returning (recrudescence) after the short-lived Artemether has cleared.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, the dispersible tablet is a technically demanding product that serves a massive public health niche:

  • Dispersibility Standards: As a WHO-GMP quality parameter, these tablets must disintegrate in a small amount of water or milk within 1 to 2 minutes to form a smooth suspension, ensuring the child receives the full dose without the risk of choking.

  • Taste-Masking Technology: Artemether and Lumefantrine are naturally very bitter. For a manufacturing firm, the use of advanced sweetening and flavoring agents (such as cherry or strawberry) is essential to prevent the child from spitting out the medicine.

  • Stabilization for Tropical Climates: Both APIs, particularly Artemether, are sensitive to heat and moisture. We utilize Alu-Alu blister packaging to ensure a 24-month shelf life in Zone IVb environments (hot and humid), common in Africa and Southeast Asia.

  • Global Health Tenders: These are high-volume essential medicines for international NGOs, UNICEF, and the Global Fund. Our Mumbai facility is optimized for the high-capacity production and the rigorous CTD/eCTD documentation required for these global contracts.

Artemether & Lumefantrine Tablets

Posted on:

What is the use of Artemether and Lumefantrine tablets?

In the pharmaceutical industry, Artemether and Lumefantrine tablets (commonly in 20 mg/120 mg or 80 mg/480 mg strengths) represent the gold standard in Artemisinin-based Combination Therapy (ACT). As a pharmacist, I view this specific fixed-dose combination (FDC) as the most critical frontline defense against multi-drug resistant malaria.

Primary Clinical Uses

  • Uncomplicated Malaria: Indicated for the treatment of acute, uncomplicated malaria infections caused by Plasmodium falciparum, including infections acquired in chloroquine-resistant areas.

  • Pediatric and Adult Populations: Used widely across all age groups (standardized by weight) to ensure rapid clearance of parasites from the blood.

  • Stand-by Emergency Treatment: Often carried by travelers to malaria-endemic regions as a self-administered emergency treatment when medical facilities are unavailable.

Mechanism of Action

This combination provides a dual-phase attack on the malaria parasite:

Artemether: A semi-synthetic derivative of artemisinin. It acts rapidly to provide a fast “knockdown” of the parasite load by generating reactive free radicals that disrupt the parasite’s membrane and proteins.

Lumefantrine: A long-acting fluorene derivative. It acts more slowly but stays in the system longer to clear any residual parasites that survived the initial Artemether burst, preventing recrudescence (relapse).

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Artemether-Lumefantrine is a high-precision product requiring stringent quality controls:

  • Fixed-Dose Combination (FDC) Stability: Artemether is a relatively unstable molecule sensitive to heat and moisture. As a WHO-GMP manufacturer, we utilize specialized granulation processes and Alu-Alu blister packaging to ensure stability, particularly for export to the high-heat environments of Africa and Southeast Asia.

  • Bioavailability: Lumefantrine has highly variable absorption. Our formulation includes specific excipients to ensure consistent absorption, especially when taken with fatty foods, which is a critical clinical requirement.

  • Global Health Tenders: This is a high-volume item for international NGOs, UNICEF, and the Global Fund. Our Mumbai-based facility is optimized to meet the massive demand for these tenders with full CTD/eCTD Dossier support.

  • Pediatric Dispersible Tablets: We also focus on dispersible formulations with pleasant flavoring to ensure easy administration and compliance in children, which is vital for reducing child mortality.

Artemether & Lumefantrine Tablets

Add to cart